InvestorRelations
Please contact us for any investor information using the form below.
CurrentNews
Revolutionizing Adult Epilepsy Treatment: Our Expanded Research Using Super SNEDDS Technology
November 8, 2024
In the evolving landscape of neurological disorders, epilepsy stands out as a complex challenge that affects millions of adults worldwide. The quest for more effective ...
Read More →
EmpowerPharm Inc. is delighted to announce the outcome of their Phase 2 clinical trial assessing Cannabidiol (CBD) drug product for Social Anxiety Disorder (SAD)
June 6, 2024
EmpowerPharm Inc. https://empowerpharm.ca/ is delighted to announce the outcome of their Phase 2 clinical trial assessing the dose finding, efficacy, safety, and tolerability of Cannabidiol ...
Read More →
EMPOWERPHARM AWAITS PHASE II CLINICAL TRIAL ON GROUND BREAKING TREATMENT TO MANAGE SOCIAL ANXIETY DISORDER
March 11, 2024
Burlington, ON March 11, 2024 - EmpowerPharm Inc. is delighted to announce that the final participant has completed their treatment in the Phase II clinical ...
Read More →